FBI (US Federal Bureau of Investigation) takes documents from Medi-Hut premises:
This article was originally published in Clinica
Medi-Hut, the Lakewood, New Jersey-based maker of safety syringes, says the US Federal Bureau of Investigation removed documents and computers from its headquarters after obtaining a search warrant. The company says it has "not been advised of the nature of the US Government's investigation". Meanwhile, Medi-Hut's move to new headquarters should be completed by December 2. This summer the US Securities and Exchange Commission launched an investigation into Medi-Hut's financial disclosures and internal accounting controls (see Clinica No 1015, p 18).
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.